Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

LS ARK Genomic Revolution Tracker ETP Securities XS2399368062

1.69
EUR
0.00
EUR
0.21 %
17.06.2025
NAV

Nettoinventarwert (NAV)

1.96 USD 0.04 USD 1.91 %
Vortag 1.92 USD Datum 16.06.2025

LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX
LS ARK Genomic Revolution Tracker ETP Securities Chart

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Maker ETP USD Acc CH1135202138 91.03%
21Shares Aave ETP CH1135202120 64.68%
21Shares Sui Staking ETP CH1360612159 41.98%
21Shares Bitcoin Cash ETP CH0475552201 39.87%
21Shares Core Ethereum ETP Acc CH1209763130 37.74%
21Shares Ethereum Staking ETP CH0454664027 37.31%
21Shares Injective Staking ETP CH1360612134 23.30%
21Shares Immutable ETP CH1360612142 -9.65%
Name ISIN Performance
21Shares Bytetree BOLD ETP CH1146882308 21.87%
21Shares Maker ETP USD Acc CH1135202138 16.28%
21Shares Bitcoin Core ETP CH1199067674 1.05%
21Shares Bitcoin ETP CH0454664001 0.41%
21Shares XRP ETP CH0454664043 -5.07%
21Shares Sui Staking ETP CH1360612159 -34.44%
21Shares Injective Staking ETP CH1360612134 -58.84%
21Shares Immutable ETP CH1360612142 -74.12%
Name ISIN Performance
21Shares XRP ETP CH0454664043 365.81%
21Shares Aave ETP CH1135202120 230.68%
21Shares Stellar ETP CH1109575535 165.32%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 87.94%
21Shares Bitcoin Core ETP CH1199067674 60.36%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’012.11%
21Shares Aave ETP CH1135202120 448.49%
21Shares XRP ETP CH0454664043 367.89%
21Shares Bitcoin Cash ETP CH0475552201 327.80%
21Shares Bitcoin Core ETP CH1199067674 318.79%

Fundamentaldaten

Valor
ISIN XS2399368062
Emittent Leverage Shares PLC
Aufgelegt in Ireland
Auflagedatum 10.12.2021
Kategorie Trading - Leveraged/Inverse Aktien
Währung USD
Volumen 607’978.84
Depotbank
Geschäftsjahresende
Berichtsstand 17.06.2025

Anlagepolitik

So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.

ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities

Performance 1 Jahr
-6.67
Performance 2 Jahre
-33.84
Performance 3 Jahre
-20.05
Performance 5 Jahre -
Performance 10 Jahre -